ETON
Eton Pharmaceuticals, Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
53.67
close · 2026-10-29
value
3
cheaper than peers3
quality
98
stronger fundamentals98
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
41 peerswide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 21.05× | 17 |
| EV to EBITDA | 68.70× | 17 |
| price to book | 32.59× | 10 |
| price to sales | 16.77× | 4 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 98.6% | 96 |
| return on equity | 36.0% | 93 |
| operating margin | 35.8% | 86 |
| debt to equity | 62.7% | 59 |
4 of 4 measures available
Facts
| market cap | $2B |
| free cash flow | $6.6M |
| employees | 44 |
| first trade | 2018-11-13 |
| next earnings | 2026-11-05 |
| fundamentals updated | 2026-09-02 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 | 2021 |
| diluted eps | -0.17 | -0.15 | -0.04 | -0.36 | not reported |
| free cash flow | $10.2M | -$9.0M | $6.0M | $2.0M | not reported |
| net income | -$4.6M | -$3.8M | -$936,000 | -$9.0M | not reported |
| revenue | $80.0M | $39.0M | $31.6M | $21.3M | not reported |
| unusual items | not reported | not reported | $0 | $0 | $546,000 |